Dieses Maus Monoklonal-Antikörper erkennt spezifisch Carboxy Methyl Lysine in EIA, WB, IHC (fro), IF und IHC (p). Er zeigt eine Reaktivität gegenüber .
Produktnummer ABIN1105660
Kurzübersicht für Carboxy Methyl Lysine Antikörper (ABIN1105660)
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
0.1 mg/mL
Buffer
PBS, 0.02 % Sodium Azide, 0.1 % BSA
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C
Informationen zur Lagerung
Store undiluted at 2-8 °C.
Target
Carboxy Methyl Lysine (CML)
Andere Bezeichnung
Carboxy Methyl Lysine
Substanzklasse
Amino Acid
Hintergrund
CML is known to be formed from the oxidation of both carbohydrates and lipids. This makes CML a biomarker of general oxidative stress. Carboxymethyl-lysine (CML) is a well-characterized glycoxidation product that accumulates in tissues with age, and its rate of accumulation is accelerated in diabetes. Glycoxidation products are a subset of advanced glycation endproducts (AGEs) that are formed by the nonenzymatic glycation and subsequent irreversible oxidation of proteins. Oxidative stress and protein modification have been implicated in the pathogenesis of the chronic complications of diabetes, including nephropathy and atherosclerosis. The accumulation of CML in long-lived tissue such as skin collagen reflects oxidative stress over an extended period of the life-span, and has been shown to be greater in patients with diabetic complications than those without complications.Synonyms: CML, Carboxymethyl-lysine